A Randomized, Two-Treatments, Two-Periods, Crossover, Open label, Laboratory-Blind, Single Dose Bioequivalence Study between Vildagliptin/Metformin 50 mg/1000 mg Film Coated Tablets (Sensityn®) and Galvusmet® 50 mg/1000 mg Film Coated Tablets in healthy adults under fed conditions

.blurhash-client-img { display: none !important; }

Open Access

|Oct 2023

Authors

Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia

Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia

Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia

Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia

Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia

Alpha Pharma, Research & Development Dept., King Abdullah Economic City, Rabigh, Kingdom of Saudi Arabia

Charles University, Third Faculty of Medicine, Prague, Czech Republic

Language: English

Page range: 1 - 9

Submitted on: Aug 16, 2023

Accepted on: Aug 30, 2023

Published on: Oct 20, 2023

Published by: Comenius University in Bratislava, Faculty of Pharmacy

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Related subjects:

© 2023 J. Shiekmydeen, T. Siddiqi, K. Chakraborty, S. Khalaf, M. Albarazi, I. Eqtefan, J. Sliva, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.